2022
Incorporating Black women's perspectives into long-acting reversible contraception implementation.
F&S reports
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Pregnancy , 109 publications
- Contraceptive Agents, Female , 53 publications
- Medroxyprogesterone Acetate , 43 publications
- Menopause , 39 publications
Research activity
My publications
Filter publications
310 publications
2022
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.
Contraception
PubMed • Publisher's site2022
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
Contraception
PubMed • Publisher's site2022
Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer.
Menopause (New York, N.Y.)
PubMed • Publisher's site2022
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Contraception
PubMed • Publisher's site